SH
SHSAX
ETF
SHSAX
·
UNKNOWN
·
141 holdings
About SHSAX
No description available for this ETF.
Fund Details
- Expense Ratio
- —
- Inception Date
- —
- Prev. Close
- $62.66
- Exchange
- UNKNOWN
- Currency
- USD
- Holdings As Of
- Apr 10, 2026
- Tracked Holdings
- 84.4%
- HHI Score
- 352.87
- Top Sector
- Healthcare (95.500842%)
Positive 1W (+0.79%) after negative 1M (-2.32%) — trend may be reversing
47.98%
Moderately Concentrated
Diversified
Concentrated
The top 10 holdings represent 47.98% of the fund. A moderate concentration level — the fund balances top holdings with broader diversification.
Weighted by position size
Weighted avg. of top holdings
▼ -1.46%
TMO
Thermo Fisher Scientific Inc
UNH
UnitedHealth Group Inc
ISRG
Intuitive Surgical Inc
All Holdings (141)
Top 10: 47.98% of fund
| # |
Ticker |
Name |
Weight |
Shares |
Market Value |
| 1 |
LLY
|
Eli Lilly & Co |
10.89% |
687,214 |
739.08 M |
| 2 |
JNJ
|
Johnson & Johnson |
8.37% |
2.75 M |
568.32 M |
| 3 |
ABT
|
Abbott Laboratories |
5.03% |
2.65 M |
341.31 M |
| 4 |
ABBV
|
AbbVie Inc |
3.97% |
1.18 M |
269.32 M |
| 5 |
TMO
|
Thermo Fisher Scientific Inc |
3.69% |
424,384 |
250.74 M |
| 6 |
UNH
|
UnitedHealth Group Inc |
3.57% |
736,018 |
242.72 M |
| 7 |
AMGN
|
Amgen Inc |
3.41% |
670,330 |
231.57 M |
| 8 |
MDT
|
Medtronic PLC |
3.37% |
2.17 M |
228.50 M |
| 9 |
GILD
|
Gilead Sciences Inc |
2.94% |
1.59 M |
199.49 M |
| 10 |
ISRG
|
Intuitive Surgical Inc |
2.75% |
325,960 |
186.93 M |
| 11 |
BSX
|
Boston Scientific Corp |
2.75% |
1.84 M |
186.55 M |
| 12 |
DHR
|
Danaher Corp |
2.25% |
674,518 |
152.97 M |
| 13 |
SYK
|
Stryker Corp |
2.24% |
410,154 |
152.24 M |
| 14 |
EW
|
Edwards Lifesciences Corp |
2.23% |
1.75 M |
151.50 M |
| 15 |
MRK
|
Merck & Co Inc |
2.06% |
1.34 M |
140.00 M |
| 16 |
ALNY
|
Alnylam Pharmaceuticals Inc |
1.96% |
295,219 |
133.21 M |
| 17 |
MCK
|
McKesson Corp |
1.72% |
132,195 |
116.48 M |
| 18 |
COR
|
Cencora Inc |
1.62% |
298,082 |
109.97 M |
| 19 |
AZN
|
AstraZeneca PLC |
1.25% |
459,512 |
85.20 M |
| 20 |
ROG
|
Roche Holding AG |
1.21% |
214,550 |
82.19 M |
| 21 |
REGN
|
Regeneron Pharmaceuticals Inc |
1.15% |
99,733 |
77.81 M |
| 22 |
TEVA
|
Teva Pharmaceutical Industries |
1.08% |
2.73 M |
73.49 M |
| 23 |
BMY
|
Bristol-Myers Squibb Co |
1.01% |
1.40 M |
68.84 M |
| 24 |
INSM
|
Insmed Inc |
1.00% |
326,291 |
67.79 M |
| 25 |
ARGX
|
Argenx SE |
0.97% |
72,459 |
66.08 M |
| 26 |
HCA
|
HCA Healthcare Inc |
0.96% |
128,427 |
65.28 M |
| 27 |
A
|
Agilent Technologies Inc |
0.92% |
406,802 |
62.44 M |
| 28 |
VRTX
|
Vertex Pharmaceuticals Inc |
0.91% |
143,095 |
62.05 M |
| 29 |
BIIB
|
Biogen Inc |
0.89% |
330,978 |
60.27 M |
| 30 |
RYTM
|
Rhythm Pharmaceuticals Inc |
0.88% |
550,460 |
60.05 M |
| 31 |
IDXX
|
IDEXX Laboratories Inc |
0.85% |
76,237 |
57.40 M |
| 32 |
EXAS
|
Exact Sciences Corp |
0.84% |
559,938 |
56.72 M |
| 33 |
IQV
|
IQVIA Holdings Inc |
0.76% |
224,389 |
51.61 M |
| 34 |
WAT
|
Waters Corp |
0.67% |
112,688 |
45.46 M |
| 35 |
DXCM
|
Dexcom Inc |
0.63% |
678,143 |
43.04 M |
| 36 |
INCY
|
Incyte Corp |
0.62% |
404,753 |
42.28 M |
| 37 |
PEN
|
Penumbra Inc |
0.59% |
136,101 |
39.90 M |
| 38 |
LH
|
Labcorp Holdings Inc |
0.56% |
141,526 |
38.04 M |
| 39 |
GH
|
Guardant Health Inc |
0.55% |
343,956 |
37.29 M |
| 40 |
NUVL
|
Nuvalent Inc |
0.52% |
322,681 |
35.29 M |
| 41 |
PTGX
|
Protagonist Therapeutics Inc |
0.50% |
378,430 |
34.06 M |
| 42 |
WST
|
West Pharmaceutical Services I |
0.47% |
116,000 |
32.16 M |
| 43 |
NTRA
|
Natera Inc |
0.47% |
133,100 |
31.79 M |
| 44 |
GALD
|
Galderma Group AG |
0.46% |
156,652 |
31.27 M |
| 45 |
PFE
|
Pfizer Inc |
0.46% |
1.21 M |
31.15 M |
| 46 |
ELV
|
Elevance Health Inc |
0.45% |
90,524 |
30.62 M |
| 47 |
PODD
|
Insulet Corp |
0.44% |
91,564 |
29.96 M |
| 48 |
CVS
|
CVS Health Corp |
0.43% |
367,062 |
29.50 M |
| 49 |
UCB
|
UCB SA |
0.38% |
92,407 |
25.83 M |
| 50 |
VEEV
|
Veeva Systems Inc |
0.36% |
101,554 |
24.40 M |
| 51 |
THC
|
Tenet Healthcare Corp |
0.36% |
111,596 |
24.20 M |
| 52 |
RGEN
|
Repligen Corp |
0.35% |
139,542 |
23.86 M |
| 53 |
BRKR
|
Bruker Corp |
0.35% |
482,169 |
23.53 M |
| 54 |
COO
|
Cooper Cos Inc/The |
0.34% |
299,483 |
23.34 M |
| 55 |
CNC
|
Centene Corp |
0.32% |
557,433 |
21.93 M |
| 56 |
DGX
|
Quest Diagnostics Inc |
0.32% |
113,440 |
21.46 M |
| 57 |
UTHR
|
United Therapeutics Corp |
0.30% |
41,636 |
20.24 M |
| 58 |
MRUS
|
Merus NV |
0.29% |
206,777 |
19.88 M |
| 59 |
HUM
|
Humana Inc |
0.29% |
80,397 |
19.76 M |
| 60 |
ILMN
|
Illumina Inc |
0.29% |
149,093 |
19.60 M |
| 61 |
GEHC
|
GE HealthCare Technologies Inc |
0.27% |
231,768 |
18.54 M |
| 62 |
BMRN
|
BioMarin Pharmaceutical Inc |
0.27% |
329,622 |
18.44 M |
| 63 |
STE
|
STERIS PLC |
0.26% |
66,341 |
17.67 M |
| 64 |
CYTK
|
Cytokinetics Inc |
0.25% |
251,375 |
17.13 M |
| 65 |
4568
|
Daiichi Sankyo Co Ltd |
0.25% |
688,300 |
16.96 M |
| 66 |
BBIO
|
Bridgebio Pharma Inc |
0.22% |
209,311 |
15.07 M |
| 67 |
STOK
|
Stoke Therapeutics Inc |
0.22% |
483,398 |
14.94 M |
| 68 |
APGE
|
Apogee Therapeutics Inc |
0.22% |
207,345 |
14.92 M |
| 69 |
MRNA
|
Moderna Inc |
0.22% |
572,943 |
14.89 M |
| 70 |
IONS
|
Ionis Pharmaceuticals Inc |
0.21% |
173,690 |
14.37 M |
| 71 |
ACLX
|
Arcellx Inc |
0.20% |
186,729 |
13.58 M |
| 72 |
TECH
|
Bio-Techne Corp |
0.19% |
198,125 |
12.78 M |
| 73 |
PTCT
|
PTC Therapeutics Inc |
0.18% |
145,525 |
12.51 M |
| 74 |
NBIX
|
Neurocrine Biosciences Inc |
0.18% |
80,426 |
12.24 M |
| 75 |
RCUS
|
Arcus Biosciences Inc |
0.18% |
465,407 |
12.15 M |
| 76 |
MBX
|
MBX Biosciences Inc |
0.17% |
340,569 |
11.75 M |
| 77 |
ELAN
|
Elanco Animal Health Inc |
0.17% |
493,714 |
11.49 M |
| 78 |
HOLX
|
Hologic Inc |
0.16% |
141,365 |
10.60 M |
| 79 |
EXEL
|
Exelixis Inc |
0.15% |
236,668 |
10.45 M |
| 80 |
LBRX
|
LB Pharmaceuticals Inc |
0.15% |
579,919 |
10.32 M |
| 81 |
CRL
|
Charles River Laboratories Int |
0.15% |
57,394 |
10.22 M |
| 82 |
SRRK
|
Scholar Rock Holding Corp |
0.15% |
231,108 |
10.18 M |
| 83 |
ROIV
|
Roivant Sciences Ltd |
0.15% |
478,695 |
9.96 M |
| 84 |
ADARX PHARMACEUTICAL
|
ADARX PHARMACEUTICALS INC |
0.14% |
769,230 |
9.62 M |
| 85 |
GKOS
|
Glaukos Corp |
0.14% |
89,037 |
9.46 M |
| 86 |
LARONDE INC
|
LARONDE INC |
0.14% |
386,520 |
9.39 M |
| 87 |
KARTOS THERAPEUTICS
|
KARTOS THERAPEUTICS INC |
0.13% |
1.57 M |
8.94 M |
| 88 |
BBOT
|
BridgeBio Oncology Therapeutic |
0.12% |
688,356 |
8.47 M |
| 89 |
IRON
|
Disc Medicine Inc |
0.12% |
88,432 |
8.26 M |
| 90 |
BIO
|
Bio-Rad Laboratories Inc |
0.12% |
25,295 |
8.22 M |
| 91 |
NVCR
|
Novocure Ltd |
0.11% |
586,731 |
7.52 M |
| 92 |
OLMA
|
Olema Pharmaceuticals Inc |
0.11% |
259,430 |
7.35 M |
| 93 |
RNA
|
Avidity Biosciences Inc |
0.11% |
101,637 |
7.29 M |
| 94 |
TERN
|
Terns Pharmaceuticals Inc |
0.11% |
256,540 |
7.21 M |
| 95 |
SMMT
|
Summit Therapeutics Inc |
0.10% |
397,896 |
7.12 M |
| 96 |
ENTA
|
Enanta Pharmaceuticals Inc |
0.10% |
502,656 |
7.10 M |
| 97 |
ASND
|
Ascendis Pharma A/S |
0.10% |
32,926 |
6.99 M |
| 98 |
MTD
|
Mettler-Toledo International I |
0.10% |
4,693 |
6.93 M |
| 99 |
EWTX
|
Edgewise Therapeutics Inc |
0.10% |
261,711 |
6.81 M |
| 100 |
DYN
|
Dyne Therapeutics Inc |
0.09% |
284,975 |
6.24 M |
| 101 |
ZEAL
|
Zealand Pharma A/S |
0.09% |
75,695 |
6.08 M |
| 102 |
VTYX
|
Ventyx Biosciences Inc |
0.09% |
603,440 |
6.03 M |
| 103 |
KAILERA THERAPEUTICS
|
KAILERA THERAPEUTICS INC |
0.09% |
428,000 |
5.99 M |
| 104 |
INSITRO INC
|
INSITRO INC |
0.09% |
592,636 |
5.93 M |
| 105 |
ORKA
|
Oruka Therapeutics Inc |
0.08% |
189,022 |
5.69 M |
| 106 |
UPB
|
Upstream Bio Inc |
0.08% |
197,564 |
5.65 M |
| 107 |
QUANTA DIALYSIS TECH
|
QUANTA DIALYSIS TECHNOLOGIES LTD |
0.08% |
80.02 M |
5.51 M |
| 108 |
ALC
|
Alcon AG |
0.08% |
66,973 |
5.31 M |
| 109 |
GENESIS THERAPEUTICS
|
GENESIS THERAPEUTICS INC |
0.07% |
823,870 |
4.56 M |
| 110 |
DNLI
|
Denali Therapeutics Inc |
0.07% |
234,300 |
4.56 M |
| 111 |
PCVX
|
Vaxcyte Inc |
0.07% |
89,436 |
4.44 M |
| 112 |
BNTX
|
BioNTech SE |
0.07% |
42,829 |
4.42 M |
| 113 |
BEAM
|
Beam Therapeutics Inc |
0.06% |
171,649 |
4.35 M |
| 114 |
VKTX
|
Viking Therapeutics Inc |
0.06% |
107,335 |
3.95 M |
| 115 |
KYMR
|
Kymera Therapeutics Inc |
0.06% |
55,346 |
3.76 M |
| 116 |
BHVN
|
Biohaven Ltd |
0.05% |
356,386 |
3.57 M |
| 117 |
LEGN
|
Legend Biotech Corp |
0.05% |
126,380 |
3.50 M |
| 118 |
QURE
|
uniQure NV |
0.05% |
122,925 |
3.38 M |
| 119 |
RGNX
|
REGENXBIO Inc |
0.04% |
219,311 |
2.94 M |
| 120 |
CGON
|
CG oncology Inc |
0.04% |
60,803 |
2.73 M |
| 121 |
BRIDGEBIO ONCOLOGY T
|
BRIDGEBIO ONCOLOGY THERAPEUTICS INC |
0.04% |
209,287 |
2.58 M |
| 122 |
CELLARITY INC
|
CELLARITY INC |
0.03% |
858,333 |
2.03 M |
| 123 |
ALLO
|
Allogene Therapeutics Inc |
0.03% |
1.24 M |
1.80 M |
| 124 |
NYXH
|
Nyxoah SA |
0.02% |
344,664 |
1.65 M |
| 125 |
VYGR
|
Voyager Therapeutics Inc |
0.02% |
379,198 |
1.55 M |
| 126 |
FDMT
|
4D Molecular Therapeutics Inc |
0.02% |
129,009 |
1.50 M |
| 127 |
VIR
|
Vir Biotechnology Inc |
0.02% |
228,276 |
1.47 M |
| 128 |
GOLDFINCH BIO INC
|
GOLDFINCH BIO INC |
0.02% |
3.52 M |
1.41 M |
| 129 |
AFFINIVAX INC
|
AFFINIVAX INC |
0.02% |
122,824 |
1.26 M |
| 130 |
OBIO
|
Orchestra BioMed Holdings Inc |
0.02% |
210,594 |
1.12 M |
| 131 |
AUTL
|
Autolus Therapeutics PLC |
0.02% |
744,753 |
1.05 M |
| 132 |
VOR
|
Vor BioPharma Inc |
0.01% |
117,570 |
979,358.1 |
| 133 |
TCRX
|
TScan Therapeutics Inc |
0.01% |
568,707 |
631,264.77 |
| 134 |
2223637D
|
ABIOMED Inc |
0.01% |
243,643 |
562,815.33 |
| 135 |
MAZE
|
Maze Therapeutics Inc |
0.00% |
6,131 |
231,445.25 |
| 136 |
BPMC
|
BLUEPRINT MEDICINES CORP |
0.00% |
204,909 |
200,810.82 |
| 137 |
MRTX
|
MIRATI THERAPEUTICS INC |
0.00% |
228,510 |
178,237.8 |
| 138 |
CARBON HEALTH TECHNO
|
CARBON HEALTH TECHNOLOGIES INC |
0.00% |
2.72 M |
27,202.77 |
| 139 |
EXO IMAGING INC
|
EXO IMAGING INC |
0.00% |
19,083 |
7,060.71 |
| 140 |
SWIFT HEALTH SYSTEMS
|
SWIFT HEALTH SYSTEMS INC |
0.00% |
1,700 |
3,791.01 |
| 141 |
FREQUENCY THERAPEUTI
|
FREQUENCY THERAPEUTICS CVR |
0.00% |
428,010 |
4.28 |
Showing top 10 of 141 holdings
·
Listed: 99.48%
·
0.52% in other positions
{"event":"ticker_viewed","properties":{"ticker":"SHSAX","listing_kind":"etf","pathname":"/etfs/shsax","exchange":"UNKNOWN"}}
